Good afternoon :)
$
₹
Mesa Laboratories Inc

Mesa Laboratories Inc

MLAB

NASDAQ
Asset Logo

Mesa Laboratories Inc

MLAB

NASDAQ
$120.832.48% (-3.07)
$
₹
$120.832.48% (-3.07)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Technology

Scientific & Technical Instruments

Small Cap

With a market cap of $692.4M the stock is ranked 3108

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

147.30
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

3.79
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$0.84
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

1.92%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

0.5%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 4 analysts' reports

Buy
2 analysts
Hold
1 analyst
Sell
1 analyst

Analysts expect a -2.82% price downside over the next year

Current Price$120.83
Target Price$117.5

Company Profile

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Peers

Peers

Thermo Fisher Scientific Inc
TMO
Thermo Fisher Scientific Inc
P/E Ratio
32.42
32.42
1Y Return
26.68%
26.68%
Buy Reco %
80.64
80.64
IQVIA Holdings Inc
IQV
IQVIA Holdings Inc
P/E Ratio
31.91
31.91
1Y Return
39.76%
39.76%
Buy Reco %
69.56
69.56
Agilent Technologies Inc
A
Agilent Technologies Inc
P/E Ratio
28.96
28.96
1Y Return
15.53%
15.53%
Buy Reco %
82.35
82.35
Waters Corporation
WAT
Waters Corporation
P/E Ratio
102.48
102.48
1Y Return
37.06%
37.06%
Buy Reco %
31.81
31.81
Illumina Inc
ILMN
Illumina Inc
P/E Ratio
39.30
39.30
1Y Return
114.68%
114.68%
Buy Reco %
55.00
55.00

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
TechnologyScientific & Technical Instruments

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Mesa Laboratories Inc 147.303.790
Thermo Fisher Scientific Inc32.424.301.82
IQVIA Holdings Inc31.917.140.97

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

60.7
2.4
65.1
3.6
63.7
-4.1
60.1
2.8
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue58.9058.1757.8362.8462.1359.5460.7365.1263.7260.13
Net Income-254.583.383.42-1.67-7.114.742.473.63-4.132.83
Net Profit Margin-432.19%5.82%5.92%-2.66%-11.44%7.96%4.07%5.57%-6.49%4.70%
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. Mesa Laboratories Inc (MLAB) share price today is $120.83 as of September 11, 2026 at 1:30 AM IST. The stock touched a day high of $124.76 and a day low of $120.83.

  2. Mesa Laboratories Inc stock trades on NASDAQ under the ticker symbol MLAB.

  3. Mesa Laboratories Inc's market capitalization is $692.43M as of September 11, 2026 at 1:30 AM IST.

  4. Mesa Laboratories Inc's price-to-earnings (P/E) ratio is 147.30 as of September 10, 2026.

  5. Mesa Laboratories Inc's price-to-book (P/B) ratio is 3.79 as of September 10, 2026.

  6. Yes, Mesa Laboratories Inc pays a dividend, with a current dividend yield of 0.5%.

  7. Yes, You can buy Mesa Laboratories Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Mesa Laboratories Inc shares in three steps: 1. Search Mesa Laboratories Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Mesa Laboratories Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Mesa Laboratories Inc (MLAB) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0827 shares at the current price of $120.83.

Loading...